Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Quan

Showing results (561-570 of 562) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 562 results.
Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
Infectious Diseases of Poverty|August 6, 2016
A practical community-based response strategy to interrupt Ebola transmission in sierra Leone, 2014-2015Zhong-Jie Li, Wen-Xiao Tu, Xiao-Chun Wang, et al.
Pageof 57

Showing results (561-570 of 562) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 562 results.
Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
Infectious Diseases of Poverty|August 6, 2016
A practical community-based response strategy to interrupt Ebola transmission in sierra Leone, 2014-2015Zhong-Jie Li, Wen-Xiao Tu, Xiao-Chun Wang, et al.
Pageof 57